Dec 22 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO
* Aurinia Pharmaceuticals Inc - Underwriters have agreed to purchase 11.1 million units from company at price of us$2.25 per unit
* Aurinia Pharmaceuticals - Intends to use net proceeds of offering for research,development activities, including ln phase 3 clinical trial activities
* Aurinia announces $25.0 million bought deal financing Source text for Eikon: Further company coverage: AUP.TO